KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Depreciation & Amortization (CF): 2018-2025

Historic Depreciation & Amortization (CF) for Adaptive Biotechnologies (ADPT) over the last 7 years, with Sep 2025 value amounting to $4.0 million.

  • Adaptive Biotechnologies' Depreciation & Amortization (CF) fell 4.43% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.5 million, marking a year-over-year decrease of 2.03%. This contributed to the annual value of $19.3 million for FY2024, which is 13.38% down from last year.
  • Per Adaptive Biotechnologies' latest filing, its Depreciation & Amortization (CF) stood at $4.0 million for Q3 2025, which was down 2.43% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Depreciation & Amortization (CF) ranged from a high of $5.7 million in Q4 2024 and a low of $2.3 million during Q1 2021.
  • In the last 3 years, Adaptive Biotechnologies' Depreciation & Amortization (CF) had a median value of $5.0 million in 2023 and averaged $4.8 million.
  • As far as peak fluctuations go, Adaptive Biotechnologies' Depreciation & Amortization (CF) surged by 128.44% in 2021, and later dropped by 22.10% in 2024.
  • Quarterly analysis of 5 years shows Adaptive Biotechnologies' Depreciation & Amortization (CF) stood at $4.5 million in 2021, then grew by 8.76% to $4.9 million in 2022, then rose by 2.18% to $5.0 million in 2023, then grew by 15.78% to $5.7 million in 2024, then declined by 4.43% to $4.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $4.0 million for Q3 2025, versus $4.1 million for Q2 2025 and $4.7 million for Q1 2025.